Overview

Vancomycin Tissue Concentrations by Bier Block or Intravenous Administration

Status:
Enrolling by invitation
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether or not giving a lower dose of antibiotics (Vancomycin) in the area where it is needed (upper extremity) is more effective at preventing infection than the current standard dose which is given intravenously (IV).
Phase:
Phase 1
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Vancomycin